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rectum during treatment for prostate immobilization, which 
positioned the imbedded detectors in direct contact with the anterior 
rectal wall. Prior to treatment, patients were scanned on the 
treatment couch of a CT-on-rails Linear Accelerator, which allowed 
precise localization of the detectors. During the patient treatment, 
dose information was collected and displayed in real time, providing a 
visual measure of dose rate and cumulative dose as a function of time. 
Patient treatment was re-planned with the two detectors contoured 
on the new CT dataset to calculate the expected cumulative dose to 
the detectors for that corresponding fraction. The daily recalculated 
dose was compared to the measurement of the delivered dose for the 
corresponding fraction. 
Results: The average deviation between the measured dose and the 
treatment planning system calculated dose over the 58 measurements 
after removing 5 outliers was -1.5% with a standard deviation of 4.0%. 
The minimum deviation observed was 0.26% (calculated dose: 191.8 
cGy, measured dose: 191.3 cGy). The maximum observed deviation for 
a detector positioned in contact with the anterior rectal wall was -
8.1% (184.7 cGy versus 169.7 cGy) which could indicate organ motion. 
Patient in-vivo results are displayed in Table 1 with in-phantom results 
for comparison. Daily in-vivo results for patient number 2 are 
displayed in Figure 1. Due to the real time nature of this detector it 
was also possible to distinguish the dose delivered by individual beams 
during treatment. 
 
 
 
Conclusions: This PSD system has proved to be an excellent in-vivo 
dosimeter, capable of measuring dose received by a patient with high 
accuracy as treatment is being delivered. This permits daily 
monitoring of the dose received by patients. The detector has the 
potential to detect internal organ motion and is certainly capable of 
alerting users if the patient is not set up properly on the basis of 
larger dose deviations (20% or above). Additionally, the detector is 
non invasive, and can be implemented with no alteration of current 
treatment practices.  
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Purpose/Objective: Radiotherapy (RT) of advanced non-small cell 
lung cancer (NSCLC) results in poor survival and high risk of lung 
toxicity. Radiotherapy in deep inspiration breath hold (DIBH) may 
reduce lung toxicity as lung volume increases. Prior to clinical 
implementation, evaluation of voluntary DIBH feasibility and 
reproducibility is necessary, since NSCLC patients often have poor 
lung function, which can further impair during a RT course. 
Materials and Methods: Nine patients were included in the study so 
far (six declined). Besides standard imaging for RT planning (4D 
computed tomography (CT) and DIBH CT), all patients had three 
additional imaging sessions including three consecutive DIBH CT at 
treatment fractions 2, 16 and 31. All DIBHs were visually guided. An 
optical marker based system was used for respiratory monitoring, 
enabling comfortable voluntary DIBH. Gating window of 2-3 mm was 
chosen at individual level, adjusted to each patient's performance, 
when coaching prior to RT planning. The patients' capability to 
increase lung volume and to perform repeated DIBH lasting 20 seconds 
or more throughout the RT course was considered a measure of 
feasibility. The reproducibility of DIBH level was evaluated as intra- 
and inter-fractional variations in DIBH lung volume and intra-
fractional changes in tumour position. As changes in tumour position 
were evaluated by manual registrations, intra-observer uncertainty of 
the registration process was evaluated as well. 
Results: Lung volume increased with DIBH compared to free breathing 
by 60% (range 35-87%; p < 0.0001; paired t-test). There was a slight 
non-significant trend (p=0.23; paired t-test) towards an increased lung 
volume at DIBH between the planning CT and the treatment days' DIBH 
CTs: 4% ± 6% (mean ± SD). No further variations in lung volume were 
observed throughout the treatment course: changes on days 16 & 31 
compared to day 2 were 0% ± 3%. Intra-fractional changes in lung 
volume were small, 1.1%± 0.8%. Intra-observer uncertainty in tumour 
registration was small, 0.2 mm ± 0.6mm three-dimensionally (3D). 
Intra-fractional changes in 3D tumour position were 2.1 mm ± 1.4 mm. 
No trend was observed throughout the course. Intra-fractional 3D 
tumour position change exceeded 3 mm in two DIBH CT sets, one 
patient suffered pneumonia at the time, the other patient had a 2 mm 
difference in chest excursion between the DIBHs on the particular 
day. The patients, who refused to enter the protocol (6/15) were on 
average 10 years older (p=0.014; t-test), which could be a potential 
bias of the study. 
Conclusions: DIBH seems feasible and reproducible intra- and inter-
fractionally during a course of NSCLC RT and is well tolerated. We are 
continuously accruing more patients in the protocol in order to 
strengthen these encouraging first results on stability and 
reproducibility of visually guided DIBH with external optical system for 
respiratory monitoring. 
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Purpose/Objective: The aim of the study was to increase total 
marrow irradiation (TMI) treatment effectiveness and time efficiency 
while minimizing the dose for non-skeletal structures. 
Materials and Methods: Twelve patients with multiple myeloma were 
treated by the following TMI method. As a target, all skeletal bones 
were contoured (Eclipse, Varian Inc.) excluding hand bones, jawbone, 
mandible and ethmoid bone. Critical organs were contoured for 
conformal avoidance. Due to the limitation in the longitudinal couch 
travel (effectively up to 135 cm), the total marrow irradiation delivery 
had to be split into two independent plans: HFS and FFS patient 
orientation. To avoid an unnecessary second CT scan, the FFS CT 
volume was generated by flipping the original HFS CT volume with our 
in-house written software. The upper body TMI plan (UTMI) covered 
the body from the head to 11 cm above knee joint, for which the 
helical tomotherapy technique was applied. The lower body TMI plan 
(LTMI) covered the body from the feet up to 6 cm below the knee 
joint, for which the direct tomotherapy technique was applied (two 
opposite fields of 90°-270°). All plans were implemented using the 
TomoHD treatment planning system (version 1.02; Accuray Inc.). The 
optimization goal was to achieve that a minimum of 85% of the target 
volume receives at least 99% of the prescription dose (12 Gy). 
Fractionation scheme was 3 x 4 Gy (three consecutive days, one 
irradiation a day). 
Results: In twelve patients, the following mean doses were obtained 
[mean±SD, Gy]: UTMI-target 12.15±0.06; LTMI-target 12.35±0.08; brain 
7.64±0.32; lenses 2.24±0.28; oral cavity 4.79±0.49; lungs 7.98±0.11; 
heart 7.51±0.29; liver 7.91±0.40; kidneys 6.46±0.27; bowel 7.51±0.26; 
bladder 6.53±0.15. Mean irradiation time [mean±SD, minutes] for 
UTMI was 35.15±3.50, and for LTMI was 12.66±0.79 (Fig.1). 
 
